Re: New Pacer: TPL's Motion for Reconsider of Certain Aspects of Claim Const 9-10-12

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

shboomer

Rank: Treasurer [?]

Points: 5302 [?]

Votes: 60 Score: 2.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: New Pacer: TPL's Motion for Reconsider of Certain Aspects of Claim Const 9-10-12

in response to

New Pacer: TPL's Motion for Reconsider of Certain Aspects of Claim Const 9-10-12

BaNosser

posted on Sep 11, 2012 04:05AM

At first glance, good news and bad news.

Good news: this whole DMA terminology bothered me with the (pardon the word but it is valid in this context) co-mingling of DMA and CPU explanations. TPL is trying to clarify and rectify any ambiguity.

Bad news: TPL is essentially acknowledging that they didn't do the fullest due diligence in their earlier research and presentations and now, a LONG time later, are scrambling to offset their oversight.